↑ トップへ ← 戻る

 Drug(薬物リスト) DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

306 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   (+)- epicatechin   Epicatechin   -   -   -   1件:
113 
 2   (-)-epicatechin   Epicatechin   -   -   -   2件:
86,
113 
 3   12 mg/kg gsk2402968   -   -   -   -   1件:
113 
 4   2011-2012 seasonal flu vaccine   -   -   -   -   2件:
3,
113 
 5   29180.00.00, 34681.00.00, 34681.01.00, 34681.02.00   -   -   -   -   1件:
113 
 6   3 mg/kg gsk2402968   -   -   -   -   1件:
113 
 7   4-benzyl-2-naphthalen-1-yl-1,2,4- thiadiazolidine-3,5-dione   -   -   -   -   1件:
113 
 8   4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione   -   -   -   -   1件:
113 
 9   5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole   -   -   -   -   1件:
113 
 10   6 mg/kg gsk2402968   -   -   -   -   1件:
113 
 11   750 mg metformin and 7.5 g l-citrulline daily p.o.   L-Citrulline, Metformin   D00944, D04966, D07706   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   1件:
113 
 12   9 mg/kg gsk2402968   -   -   -   -   1件:
113 
 13   Aav1-gamma-sarcoglycan vector injection   -   -   -   -   1件:
113 
 14   Ace-031 (extension of cohort 1 from core study, a031-03)   -   -   -   -   1件:
113 
 15   Ace-031 (extension of cohort 2 from core study, a031-03)   -   -   -   -   1件:
113 
 16   Ace-031 (extension of cohort 3 from core study, a031-03)   -   -   -   -   1件:
113 
 17   Ace-031 0.5 mg/kg q4wk   -   -   -   -   1件:
113 
 18   Ace-031 1.0 mg/kg q2wk   -   -   -   -   1件:
113 
 19   Ace-083   -   -   -   -   2件:
10,
113 
 20   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 21   Actonel once a week 5mg film coated tablets   Risedronic acid   D00942, D03234, D08484   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   1件:
113 
 22   Albuterol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
12,
13,
86,
89,
113,
231,
256,
299 
 23   Allogeneic cardiosphere-derived cells (cap-1002)   -   -   -   -   1件:
113 
 24   Anti-myostatin adnectin   -   -   -   -   1件:
113 
 25   Arginine   L-Arginine   D02982   -   -   5件:
67,
78,
113,
251,
299 
 26   Aspirin   Acetylsalicylic acid   D00109   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231 
 27   Ataluren   Ataluren   D09323   -   -   6件:
19,
113,
140,
246,
299,
329 
 28   Ataluren (ptc124)   Ataluren   D09323   -   -   2件:
113,
299 
 29   Ataluren 1000 mg   Ataluren   D09323   -   -   1件:
113 
 30   Ataluren 125 mg   Ataluren   D09323   -   -   1件:
113 
 31   Ataluren 250 mg   Ataluren   D09323   -   -   1件:
113 
 32   Atyr1940   -   -   -   -   1件:
113 
 33   Autologous bone marrow mononuclear cell transplantation   -   -   -   -   1件:
113 
 34   Avi-4658   -   -   -   -   1件:
113 
 35   Avi-4658 (eteplirsen)   Eteplirsen   D09900   1件: DMD   4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis   1件:
113 
 36   Avi-4658 (pmo)   -   -   -   -   1件:
113 
 37   Avi-4658 for injection   -   -   -   -   1件:
113 
 38   Balance   Isoxaflutole   -   -   -   8件:
5,
6,
13,
18,
81,
113,
149,
299 
 39   Biological: umbilical cord based allogenic mesenchymal stem cell   -   -   -   -   1件:
113 
 40   Bisoprolol   Bisoprolol   D00634, D02342   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
67,
86,
113 
 41   Bisoprolol fumarate   Bisoprolol   D00634, D02342   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
113 
 42   Bisphosphonate treatment   -   -   -   -   2件:
113,
299 
 43   Blood test   -   -   -   -   5件:
36,
86,
113,
162,
299 
 44   Bls-m22   -   -   -   -   1件:
113 
 45   Bmn 044   -   -   -   -   1件:
113 
 46   Bmn 044 iv 6 mg/kg   -   -   -   -   1件:
113 
 47   Bmn 044 iv 9 mg/kg   -   -   -   -   1件:
113 
 48   Bmn 044 sc 6 mg/kg   -   -   -   -   1件:
113 
 49   Bmn 053   -   -   -   -   1件:
113 
 50   Bms-986089-01, anti-myostatin   -   -   -   -   1件:
113 
 51   Botulinum toxin type a   Botulinum toxin type A   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   10件:
2,
5,
6,
7,
13,
15,
17,
70,
113,
149 
 52   Cabaletta   Trehalose   -   -   -   1件:
113 
 53   Calcichew d3 forte   -   -   -   -   1件:
113 
 54   Calcifediol   Calcifediol   D00122   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
113 
 55   Canakinumab   Canakinumab   D09315   1件: IL1B   40件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Prion diseases, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection   9件:
46,
56,
84,
106,
107,
108,
113,
266,
269 
 56   Canakinumab injection [ilaris]   Canakinumab   D09315   1件: IL1B   40件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease (IBD), Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Prion diseases, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection   1件:
113 
 57   Cap-1002   -   -   -   -   1件:
113 
 58   Capsaicin   Capsaicin   D00250   1件: TRPV1   2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   6件:
2,
6,
19,
86,
113,
226 
 59   Cardiovascular profile   -   -   -   -   1件:
113 
 60   Carvedilol   Carvedilol   D00255, D03415   5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2   12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   4件:
6,
57,
86,
113 
 61   Casimersen   Casimersen   -   -   -   1件:
113 
 62   Cat-1004   -   -   -   -   1件:
113 
 63   Cialis 10 mg film-coated tablets   Tadalafil   D02008   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   2件:
86,
113 
 64   Cialis 2.5 mg film-coated tablets   Tadalafil   D02008   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   2件:
86,
113 
 65   Cialis 20 mg film-coated tablets   Tadalafil   D02008   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   2件:
86,
113 
 66   Cialis 5 mg film-coated tablets   Tadalafil   D02008   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   2件:
86,
113 
 67   Citrulline   L-Citrulline   D07706   -   -   2件:
86,
113 
 68   Coenzyme q10   Ubidecarenone   D01065   -   -   10件:
2,
6,
8,
10,
46,
57,
113,
193,
214,
215 
 69   Coenzyme q10 and lisinopril   Ubidecarenone, Lisinopril   D00362, D01065, D08131   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   1件:
113 
 70   Cosyntropin   Tetracosactide   D00284   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
83,
113,
145 
 71   Cosyntropin acetate   Acetate, Tetracosactide   D00284   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
113 
 72   Cr13c   -   -   -   -   1件:
113 
 73   Crd007   -   -   -   -   1件:
113 
 74   Creatine   Creatine   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201 
 75   Creatine monohydrate   Creatine   -   -   -   4件:
2,
8,
113,
156 
 76   Creatine-13c   Creatine   -   -   -   1件:
113 
 77   Cyclosporin   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   16件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
97,
113,
164,
222,
223,
274,
326 
 78   Cyclosporin a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   11件:
14,
38,
39,
49,
53,
56,
60,
62,
63,
113,
164 
 79   Date   Date   -   -   -   3件:
6,
88,
113 
 80   Decortin   decortin   D00068, D02798, D04855, D06542   -   -   5件:
46,
96,
97,
113,
145 
 81   Deflazacort   Deflazacort   D03671   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
30,
113 
 82   Dehydroepiandrosterone   Prasterone   D08409   3件: AR, ESR1, ESR2   11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway   5件:
49,
53,
83,
96,
113 
 83   Dehydroepiandrosterone 100 and 400 mg   Prasterone   D08409   3件: AR, ESR1, ESR2   11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
113 
 84   Dexmedetomidine   Dexmedetomidine   D00514, D01205   3件: ADRA2A, ADRA2B, ADRA2C   2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway   11件:
2,
4,
6,
21,
34,
70,
113,
212,
215,
226,
280 
 85   Dilatrend   dilatrend   D00255, D03415   5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2   12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
113 
 86   Dosing extension   -   -   -   -   1件:
113 
 87   Drisapersen   Drisapersen   D10114   1件: DMD   4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis   1件:
113 
 88   Drisapersen sodium   Drisapersen   D10114   1件: DMD   4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis   1件:
113 
 89   Ds-5141b   -   -   -   -   1件:
113 
 90   Edasalonexent   Edasalonexent   -   -   -   1件:
113 
 91   Egcg   Epigallocatechin gallate   -   -   -   8件:
6,
13,
17,
28,
85,
113,
206,
299 
 92   Emd 87580   -   -   -   -   1件:
113 
 93   Enahexal®, 10mg   -   -   -   -   1件:
113 
 94   Enalapril   Enalapril   D00621, D07892   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   4件:
19,
46,
66,
113 
 95   Enalhexal®, 5 mg   -   -   -   -   1件:
113 
 96   Epa and dha   -   -   -   -   1件:
113 
 97   Epicatechin   Epicatechin   -   -   -   2件:
86,
113 
 98   Epigallocatechin   Epigallocatechin   -   -   -   4件:
13,
28,
85,
113 
 99   Epigallocatechin-gallate   Epigallocatechin   -   -   -   1件:
113 
 100   Eplerenone   Eplerenone   D01115   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   3件:
75,
113,
215 
 101   Erx-963   -   -   -   -   1件:
113 
 102   Eteplirsen   Eteplirsen   D09900   1件: DMD   4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis   1件:
113 
 103   Eucardic   eucardic   D00255, D03415   5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2   12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
113 
 104   Ev substance code: sub188638   -   -   -   -   1件:
113 
 105   Exondys 51   Eteplirsen   D09900   1件: DMD   4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis   1件:
113 
 106   Ezutromid   Ezutromid   -   -   -   1件:
113 
 107   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 108   Flavocoxid   -   -   -   -   1件:
113 
 109   Gentamicin   Gentamicin   D01063, D08013   -   -   3件:
36,
113,
299 
 110   Gentamicin infusions twice a week for six months   Gentamicin   D01063, D08013   -   -   1件:
113 
 111   Givinostat   Givinostat   -   -   -   1件:
113 
 112   Givinostat (hydrochloride monohydrate)   Givinostat   -   -   -   1件:
113 
 113   Givinostat (idrocloruro monoidrato)   Givinostat   -   -   -   1件:
113 
 114   Glutamine   L-Glutamine   D00015   -   -   6件:
87,
96,
97,
113,
245,
299 
 115   Golodirsen   -   -   -   -   1件:
113 
 116   Granulocyte colony-stimulating factor (filgrastim)   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
113 
 117   Gsk2402968   -   -   -   -   1件:
113 
 118   Gsk2402968 3mg/kg/week   -   -   -   -   1件:
113 
 119   Gsk2402968 6 mg/kg/week   -   -   -   -   1件:
113 
 120   Guanidine   Guanidine   D02437   -   -   1件:
113 
 121   H44aon188   -   -   -   -   1件:
113 
 122   Haemostasis tests   -   -   -   -   1件:
113 
 123   Hidroferol   -   -   -   -   1件:
113 
 124   Hidroferol®   -   -   -   -   1件:
113 
 125   Hla-identical allogeneic mesoangioblasts   -   -   -   -   1件:
113 
 126   Hmabs   -   -   -   -   1件:
113 
 127   Hormonal profile   -   -   -   -   1件:
113 
 128   Ht-100   -   -   -   -   1件:
113 
 129   Human umbilical cord mesenchymal stem cells   -   -   -   -   2件:
13,
113 
 130   Ibuprofen   Ibuprofen   D00126, D01122, D04490, D06606   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   6件:
13,
46,
65,
113,
271,
299 
 131   Ibuprofen 200mg   Ibuprofen   D00126, D01122, D04490, D06606   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   1件:
113 
 132   Idebenone   Idebenone   D01750   -   -   4件:
6,
13,
113,
302 
 133   Idebenone 150 mg film-coated tablets   Idebenone   D01750   -   -   1件:
113 
 134   Ifetroban   Ifetroban   D04500   1件: TBXA2R   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation   3件:
51,
86,
113 
 135   Igf-1   -   -   -   -   1件:
113 
 136   Inflammatory profile   -   -   -   -   1件:
113 
 137   Ionis-dmpkrx   -   -   -   -   1件:
113 
 138   Isosorbide   Isosorbide Mononitrate   D00630   -   -   1件:
113 
 139   Isosorbide dinitrate   Isosorbide Mononitrate, Isosorbide dinitrate   D00516, D00630   -   -   1件:
113 
 140   Isosorbide dinitrate 20 mg   Isosorbide Mononitrate, Isosorbide dinitrate   D00516, D00630   -   -   1件:
113 
 141   Isosorbide dinitrate 40 mg   Isosorbide Mononitrate, Isosorbide dinitrate   D00516, D00630   -   -   1件:
113 
 142   Isosorbide dinitrate 60 mg   Isosorbide Mononitrate, Isosorbide dinitrate   D00516, D00630   -   -   1件:
113 
 143   Isosorbide dinitrate 80 mg   Isosorbide Mononitrate, Isosorbide dinitrate   D00516, D00630   -   -   1件:
113 
 144   Itf2357   -   -   -   -   3件:
96,
107,
113 
 145   Ketamine   Ketamine   D00711, D08098   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway   5件:
13,
70,
113,
156,
215 
 146   L-arginine   L-Arginine   D02982   -   -   4件:
67,
78,
113,
299 
 147   L-citrulline   L-Citrulline   D07706   -   -   2件:
86,
113 
 148   L-citrulline and metformin & l-citrulline   L-Citrulline, Metformin   D00944, D04966, D07706   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   1件:
113 
 149   L-glutamine   L-Glutamine   D00015   -   -   1件:
113 
 150   Lisinopril   Lisinopril   D00362, D08131   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   5件:
46,
66,
67,
113,
222 
 151   Lonafarnib   Lonafarnib   D04768   2件: FNTA, FNTB   1件: Terpenoid backbone biosynthesis   2件:
113,
333 
 152   Losartan   Losartan   D00357, D08146   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 153   Losmapimod   Losmapimod   D09639   4件: MAPK11, MAPK12, MAPK13, MAPK14   53件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis (ALS), C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease (American trypanosomiasis), Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pertussis, Platelet activation, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection   2件:
113,
222 
 154   Metabolic profile   -   -   -   -   1件:
113 
 155   Metformin   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   16件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285 
 156   Metformin 500mg   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   1件:
113 
 157   Metformin and metformin & l-citrulline   L-Citrulline, Metformin   D00944, D04966, D07706   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   1件:
113 
 158   Methylphenidate   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   6件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle   7件:
6,
13,
34,
84,
113,
179,
206 
 159   Metohexal® succ ® 23,75 mg retardtabletten   -   -   -   -   1件:
113 
 160   Metohexal® succ ® 47,5 mg retardtabletten   -   -   -   -   1件:
113 
 161   Metohexal® succ ® 95 mg retardtabletten   -   -   -   -   1件:
113 
 162   Metoprolol   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   6件:
17,
57,
58,
113,
193,
226 
 163   Metoprolol succinate   Metoprolol   D00601, D02358, D05011   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   4件:
57,
58,
113,
193 
 164   Mexiletine   Mexiletine   D00639, D08215   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   5件:
1,
2,
10,
113,
114 
 165   Mnk-1411   -   -   -   -   1件:
113 
 166   Monocytes and megacaryocytes culture and rna extraction   -   -   -   -   1件:
113 
 167   Myo-029   MYO-029   -   -   -   1件:
113 
 168   Myoblast autologous graft   -   -   -   -   1件:
113 
 169   Myoblast transplantation   -   -   -   -   1件:
113 
 170   Myoblastes autologues   -   -   -   -   1件:
113 
 171   N(4,5bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate   Guanidine   D02437   -   -   1件:
113 
 172   Nanosuspension)   -   -   -   -   1件:
113 
 173   Nebivolol   Nebivolol   D05127   1件: ADRB1   10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
17,
113,
167 
 174   Needle biopsy of the vastus lateralis muscle   -   -   -   -   1件:
113 
 175   Nitrate   Nitrate   D02313   -   -   3件:
58,
113,
299 
 176   Npc-14   -   -   -   -   1件:
113 
 177   Ns-065/ncnp-01   Viltolarsen   D11528   1件: DMD   4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis   1件:
113 
 178   Ns-089/ncnp-02   -   -   -   -   1件:
113 
 179   Nébivolol   -   -   -   -   1件:
113 
 180   Omigapil   Omigapil   -   -   -   1件:
113 
 181   Oxatomide   Oxatomide   D01773   1件: ALOX5   6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis   1件:
113 
 182   Oxatomide (tinset)   Oxatomide   D01773   1件: ALOX5   6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis   1件:
113 
 183   P-188 nf   -   -   -   -   1件:
113 
 184   Pamrevlumab   Pamrevlumab   D10969   1件: CCN2   2件: Apelin signaling pathway, Hippo signaling pathway   2件:
85,
113 
 185   Pamrevlumab (fg-3019)   Pamrevlumab   D10969   1件: CCN2   2件: Apelin signaling pathway, Hippo signaling pathway   1件:
113 
 186   Pb1046 injection   -   -   -   -   2件:
86,
113 
 187   Pemirolast   Pemirolast   D01088, D07476   -   -   1件:
113 
 188   Pending   -   -   -   -   3件:
13,
113,
302 
 189   Pentoxifylline   Pentoxifylline   D00501   -   -   10件:
26,
56,
84,
93,
96,
113,
220,
222,
296,
298 
 190   Pf-06252616   Domagrozumab   D11047   1件: MSTN   1件: Cytokine-cytokine receptor interaction   1件:
113 
 191   Phosphorodiamidate morpholino oligomer   -   -   -   -   1件:
113 
 192   Phosphorodiamidate morpholino oligomer for exon 53 skipping   -   -   -   -   1件:
113 
 193   Powder for oral suspension)   -   -   -   -   1件:
113 
 194   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 195   Prednison   -   -   -   -   2件:
46,
113 
 196   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 197   Pro044   -   -   -   -   1件:
113 
 198   Pro044 iv 6 mg/kg   -   -   -   -   1件:
113 
 199   Pro044 iv 9 mg/kg   -   -   -   -   1件:
113 
 200   Pro044 sc 6 mg/kg   -   -   -   -   1件:
113 
 201   Pro045   -   -   -   -   1件:
113 
 202   Pro045, 0.15 mg/kg/week   -   -   -   -   1件:
113 
 203   Pro045, 1.0 mg/kg/week   -   -   -   -   1件:
113 
 204   Pro045, 3.0 mg/kg/week   -   -   -   -   1件:
113 
 205   Pro045, 6.0 mg/kg/week   -   -   -   -   1件:
113 
 206   Pro045, 9.0 mg/kg/week   -   -   -   -   1件:
113 
 207   Pro045, selected dose   -   -   -   -   1件:
113 
 208   Pro051   -   -   -   -   1件:
113 
 209   Protein-carbohydrate supplementation   -   -   -   -   1件:
113 
 210   Ps188   -   -   -   -   1件:
113 
 211   Ps188 (company code)   -   -   -   -   1件:
113 
 212   Ps220   -   -   -   -   1件:
113 
 213   Ps524   -   -   -   -   1件:
113 
 214   Ptc0161480, ptc124 compound 1a, rps2505, ptc-c124, 291844   -   -   -   -   1件:
113 
 215   Ptc124   -   -   -   -   4件:
19,
113,
246,
299 
 216   Ptc124 high dose   -   -   -   -   1件:
113 
 217   Ptc124 low dose   -   -   -   -   1件:
113 
 218   Raav1.cmv.hufollistatin344   -   -   -   -   2件:
15,
113 
 219   Raav1.cmv.hufollistin344   -   -   -   -   1件:
113 
 220   Raav2.5-cmv-minidystrophin (d3990)   -   -   -   -   1件:
113 
 221   Raavrh74.mck.galgt2   -   -   -   -   1件:
113 
 222   Raavrh74.mck.micro-dystrophin   -   -   -   -   1件:
113 
 223   Raavrh74.mhck7.micro-dystrophin   -   -   -   -   1件:
113 
 224   Ramipril   Ramipril   D00421   1件: ACE   4件: Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   7件:
46,
49,
66,
67,
113,
218,
257 
 225   Ranolazine   Ranolazine   D05700, D05701   -   -   6件:
2,
58,
86,
113,
114,
130 
 226   Raxone   Idebenone   D01750   -   -   1件:
113 
 227   Recombinant human anti-gdf-8 antibody   -   -   -   -   1件:
113 
 228   Regimen selection phase group 1 (completed)   -   -   -   -   1件:
113 
 229   Regimen selection phase group 2   -   -   -   -   1件:
113 
 230   Regimen selection phase group 3   -   -   -   -   1件:
113 
 231   Resveratrol   Resveratrol   -   -   -   3件:
8,
89,
113 
 232   Rhigf-i/rhigfbp-3   Mecasermin rinfabate, rhIGFBP-3   D04870   2件: GHR, IGF1R   33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway   1件:
113 
 233   Rhigfbp-3   rhIGFBP-3   -   -   -   2件:
113,
195 
 234   Rimeporide   Rimeporide   -   -   -   1件:
113 
 235   Risedronate   Risedronic acid   D00942, D03234, D08484   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   5件:
46,
66,
96,
113,
274 
 236   Risedronate sodium   Risedronic acid   D00942, D03234, D08484   1件: FDPS   4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   2件:
113,
274 
 237   Ro7239361   -   -   -   -   1件:
113 
 238   Ro7239361 injections, 15 mg/syringe (21.4 mg/ml)   -   -   -   -   1件:
113 
 239   Ro7239361 injections, 35 mg/syringe (50 mg/ml)   -   -   -   -   1件:
113 
 240   Ro7239361 injections, 7.5 mg/syringe (10.7 mg/ml)   -   -   -   -   1件:
113 
 241   Sandimmun   sandimmun   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   4件:
53,
60,
113,
226 
 242   Sandimmun optoral   sandimmun   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   2件:
53,
113 
 243   Scaavrh74.tmck.hsgca   -   -   -   -   1件:
113 
 244   Sildenafil   Sildenafil   D02229, D08514   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   15件:
6,
46,
50,
51,
85,
86,
113,
210,
211,
212,
225,
226,
278,
294,
299 
 245   Sleep parameters   -   -   -   -   1件:
113 
 246   Smt c1100   -   -   -   -   1件:
113 
 247   Smt c1100 (f5   -   -   -   -   1件:
113 
 248   Smt c1100 (f5)   -   -   -   -   1件:
113 
 249   Smt c1100 (f6   -   -   -   -   1件:
113 
 250   Smt c1100 (f6)   -   -   -   -   1件:
113 
 251   Snt-mc17   -   -   -   -   1件:
113 
 252   Sodium nitrate   Nitrate   D02313   -   -   2件:
58,
113 
 253   Sodium nitrate - double dose   Nitrate   D02313   -   -   1件:
113 
 254   Somatokine/iplex   -   -   -   -   1件:
113 
 255   Somatropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   15件:
2,
3,
19,
46,
74,
75,
78,
96,
113,
193,
195,
265,
274,
276,
299 
 256   Spironolactone   Spironolactone   D00443   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   6件:
58,
67,
86,
113,
218,
225 
 257   Srp-4045   -   -   -   -   1件:
113 
 258   Srp-4053   -   -   -   -   1件:
113 
 259   Srp-5051   -   -   -   -   1件:
113 
 260   Srp-9001   -   -   -   -   1件:
113 
 261   Srp-9003   -   -   -   -   1件:
113 
 262   Stem cell   -   -   -   -   2件:
2,
113 
 263   Stem cells   -   -   -   -   4件:
2,
4,
96,
113 
 264   Sunphenon   -   -   -   -   2件:
13,
113 
 265   Sunphenon egcg   Epigallocatechin gallate   -   -   -   3件:
13,
17,
113 
 266   Sustanon (testosterone)   Testosterone   D00075, D00957, D00958, D00959, D06085, D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   1件:
113 
 267   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 268   Tadalafil   Tadalafil   D02008   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   6件:
6,
51,
75,
84,
86,
113 
 269   Tadalafil 20 mg   Tadalafil   D02008   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   1件:
113 
 270   Tadalafil and sildenafil   Sildenafil, Tadalafil   D02008, D02229, D08514   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   1件:
113 
 271   Tamox   -   -   -   -   1件:
113 
 272   Tamoxifen   Tamoxifen   D00966, D08559   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   4件:
2,
86,
113,
227 
 273   Tamoxifen citrate   Tamoxifen   D00966, D08559   2件: ESR1, ESR2   9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway   1件:
113 
 274   Tas-205   -   -   -   -   1件:
113 
 275   Tehalose 30gr   -   -   -   -   1件:
113 
 276   Temerit   -   -   -   -   1件:
113 
 277   Testosterone   Testosterone   D00075, D00957, D00958, D00959, D06085, D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   7件:
1,
2,
3,
13,
78,
113,
265 
 278   Testosterone enanthate   Testosterone, Testosterone enanthate   D00075, D00957, D00958, D00959, D06085, D06087   1件: AR   3件: Oocyte meiosis, Pathways in cancer, Prostate cancer   1件:
113 
 279   Tetracosactide   Tetracosactide   D00284   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   4件:
83,
113,
145,
222 
 280   Tetracosactide hexaacetate   Tetracosactide   D00284   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
113 
 281   Tideglusib   Tideglusib   -   -   -   2件:
5,
113 
 282   Tranilast   Tranilast   D02027   -   -   4件:
46,
84,
106,
113 
 283   Translarna   Ataluren   D09323   -   -   1件:
113 
 284   Translarna 1000 mg granules for oral suspension   Ataluren   D09323   -   -   1件:
113 
 285   Translarna 125 mg granules for oral suspension   Ataluren   D09323   -   -   1件:
113 
 286   Translarna 250 mg granules for oral suspension   Ataluren   D09323   -   -   1件:
113 
 287   Treatment phase group 4   -   -   -   -   1件:
113 
 288   Triatec   -   -   -   -   1件:
113 
 289   Umbilical cord mesenchymal stem cell   -   -   -   -   1件:
113 
 290   Umbilical cord mesenchymal stem cells   -   -   -   -   5件:
13,
46,
57,
97,
113 
 291   Vamarolone   -   -   -   -   1件:
113 
 292   Vamorolone   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 293   Vamorolone 0.25 mg/day/day   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 294   Vamorolone 0.25 mg/kg/day   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 295   Vamorolone 0.75 mg/day/day   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 296   Vamorolone 0.75 mg/kg/day   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 297   Vamorolone 2.0 mg/day/day   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 298   Vamorolone 2.0 mg/kg/day   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 299   Vamorolone 6.0 mg/day/day   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 300   Vamorolone 6.0 mg/kg/day   Vamorolone   D11000   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
113 
 301   Vbp15   -   -   -   -   1件:
113 
 302   Viltolarsen   Viltolarsen   D11528   1件: DMD   4件: Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), Viral myocarditis   1件:
113 
 303   Vit c vit e zn se   -   -   -   -   1件:
113 
 304   Wve-210201   -   -   -   -   1件:
113 
 305   Wve-210201 (suvodirsen)   -   -   -   -   1件:
113 
 306   Xeomin   Botulinum toxin type A   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   7件:
5,
6,
7,
13,
15,
17,
113 

先頭へ